HOME >> BIOLOGY >> NEWS
Climate change surprise: High carbon dioxide levels can retard plant growth, study reveals

The prevailing view among scientists is that global climate change may prove beneficial to many farmers and foresters at least in the short term. The logic is straightforward: Plants need atmospheric carbon dioxide to produce food, and by emitting more CO2 into the air, our cars and factories create new sources of plant nutrition that will cause some crops and trees to grow bigger and faster.

But an unprecedented three-year experiment conducted at Stanford University is raising questions about that long-held assumption. Writing in the journal Science, researchers concluded that elevated atmospheric CO2 actually reduces plant growth when combined with other likely consequences of climate change namely, higher temperatures, increased precipitation or increased nitrogen deposits in the soil.

The results of the study may prompt researchers and policymakers to re-think one of the standard arguments against taking action to prevent global warming: that natural ecosystems will minimize the problem of fossil fuel emissions by transferring large amounts of carbon in the atmosphere to plants and soils.

"Perhaps we won't get as much help with the carbon problem as we thought we could, and we will need to put more emphasis on both managing vegetation and reducing emissions," said Harold A. Mooney, the Paul S. Achilles Professor of Environmental Biology at Stanford and co-author of the Dec. 6 Science study.

He noted that the Stanford study is the first ecosystem-scale experiment to apply four climate change factors across several generations of plants.

"To understand complex ecological systems, the traditional approach of isolating one factor and looking at that response, then extrapolating to the whole system, is often not correct," Mooney said. "On an ecosystem scale, many interacting factors may be involved."

Jasper Ridge Global Change Project

The findings published in Science are among the first results of the Jas
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
5-Dec-2002


Page: 1 2 3 4

Related biology news :

1. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
2. Climate change could doom Alaskas tundra
3. Climate may play role in lynxs hunting ability
4. Climate change Qs & As
5. Climate change may threaten more than one million species with extinction
6. Climate linked to reproduction of right whales
7. Climate change linked to migratory bird decrease
8. Climate affects recent crop yield gains
9. Climate and cholera: An increasingly important link
10. Grant from Vetlesen Foundation supports URI Graduate School of Oceanography Climate Research
11. Climate monitoring goes mobile

Post Your Comments:
(Date:10/22/2014)... Mass., Oct. 21, 2014 Aware, Inc. (NASDAQ: ... services, today reported financial results for its third quarter ended ... of 2014 was $6.0 million, an increase of 40% compared ... income in the third quarter of 2014 was $4.1 million ... Higher operating income in the current three month period was ...
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/18/2014)... with undiagnosed, suspected genetic conditions, a certain type of ... diagnostic yield than traditional molecular diagnostic methods, according to ... is being released to coincide with the American Society ... sequences the protein­coding region of the genome (the complete ... cell or organism), has been rapidly applied in research ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Researchers find why depression and aging linked to increased disease risk 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... Diabetes Federation, approximately 400 million people worldwide are living ... 552 million people by 2030.  The global market for ... In 2012 approximately 330,000 people worldwide died from pancreatic ... of death due to cancer in the ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by product ... Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient ... 2019” analyzes and studies the major market drivers, ... and the Rest of the World (RoW). , ... through 300 pages and in-depth TOC on "Pharmacy ...
(Date:10/20/2014)... Oct. 20, 2014 Asterias Biotherapeutics, Inc. ... has signed a Notice of Grant Award (NGA) ... effective October 1, 2014.  The NGA provides for ... the release of additional grant funds pursuant to ... for clinical development of Asterias, product, AST-OPC1. The ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: